Condition
Arterial Ulcer
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed2
Not Yet Recruiting1
Terminated1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07395674Not ApplicableNot Yet Recruiting
Subcutaneous Dexpanthenol Administration and Wound Epithelialization
NCT07541196Not ApplicableRecruiting
PAW-Hydrogel for Chronic Wound Healing
NCT05170984Not ApplicableCompleted
MAtrix Therapy for Hard-to-heal ChrOnic Wounds
NCT05729334Not ApplicableCompleted
Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions
NCT03275831Not ApplicableTerminated
PluroGel on Wounds of Mixed Etiology
Showing all 5 trials